{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T14:21:47Z","timestamp":1784730107687,"version":"3.55.0"},"reference-count":168,"publisher":"SAGE Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2021,11,9]]},"abstract":"<jats:p>Alzheimer\u2019s disease (AD), a progressive neurodegenerative disorder characterized by memory loss and cognitive functions decline, is a leading cause for dementia and currently ranked as the sixth foremost cause of death. As of present, treatment of AD is symptomatic without convincing therapeutic benefits and new, effective, therapeutic agents are pursued. Due to massive loss of cholinergic neurons and decreased acetylcholine levels, cholinesterase inhibitors like galantamine, remain the backbone of pharmacological treatment of the disease. In the present study, using behavioral and biochemical methods, four newly synthesized galantamine derivatives, Gal 34, Gal 43, Gal 44, and Gal 46, were evaluated for a beneficial effect in a scopolamine model of dementia in mice. They were designed to have all the advantages of galantamine and additionally to inhibit \u03b2-secretase and exert favorable effects on plasma lipids. Behavioral tests included step-through inhibitory avoidance, T-maze, and the hole-board test, whereas biochemical evaluations involved assessment of acetylcholinesterase activity, brain monoamines levels, lipid peroxidation, catalase, glutathione peroxidase, and superoxide dismutase activities along with measurement of total glutathione. Results show that Gal 43, Gal 44, and, in particular, Gal 46 are especially effective in improving both short- and long-term memory and in the case of Gal 46 having a significant effect on exploratory activity as well. Although Gal 34 did not show behavioral effects as convincing as those of the other three galantamine derivatives, it demonstrated persuasive antioxidant and restorative capacities, making all four galantamine derivatives promising AD treatment agents and prompting further research, especially that in many of our studies they performed better than galantamine.<\/jats:p>","DOI":"10.3233\/jad-215165","type":"journal-article","created":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T12:49:36Z","timestamp":1632487776000},"page":"671-690","source":"Crossref","is-referenced-by-count":16,"title":["Effects of New Galantamine Derivatives in a Scopolamine Model of Dementia in Mice"],"prefix":"10.1177","volume":"84","author":[{"given":"Maria","family":"Lazarova","sequence":"first","affiliation":[{"name":"Institute of Neurobiology, Bulgarian Academy of Sciences, Sofia, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyubka","family":"Tancheva","sequence":"additional","affiliation":[{"name":"Institute of Neurobiology, Bulgarian Academy of Sciences, Sofia, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albena","family":"Alexandrova","sequence":"additional","affiliation":[{"name":"Institute of Neurobiology, Bulgarian Academy of Sciences, Sofia, Bulgaria"},{"name":"National Sports Academy, Sofia, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elina","family":"Tsvetanova","sequence":"additional","affiliation":[{"name":"Institute of Neurobiology, Bulgarian Academy of Sciences, Sofia, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Almira","family":"Georgieva","sequence":"additional","affiliation":[{"name":"Institute of Neurobiology, Bulgarian Academy of Sciences, Sofia, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miroslava","family":"Stefanova","sequence":"additional","affiliation":[{"name":"Institute of Neurobiology, Bulgarian Academy of Sciences, Sofia, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Tsekova","sequence":"additional","affiliation":[{"name":"Department of Organic Chemistry, University of Chemical Technology and Metallurgy, Sofia, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyubomir","family":"Vezenkov","sequence":"additional","affiliation":[{"name":"Department of Organic Chemistry, University of Chemical Technology and Metallurgy, Sofia, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reni","family":"Kalfin","sequence":"additional","affiliation":[{"name":"Institute of Neurobiology, Bulgarian Academy of Sciences, Sofia, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diamara","family":"Uzunova","sequence":"additional","affiliation":[{"name":"Institute of Neurobiology, Bulgarian Academy of Sciences, Sofia, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polina","family":"Petkova-Kirova","sequence":"additional","affiliation":[{"name":"Institute of Neurobiology, Bulgarian Academy of Sciences, Sofia, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-215165_ref2","unstructured":"Prince M , Comas-Herrera A , Knapp M , Guerchet M , Karagiannidou M (2016) World Alzheimer Report 2016. Improving Healthcare for People Living with Dementia: Coverage, Quality and Costs Now and in the Future. Alzheimer\u2019s Disease International, London."},{"key":"10.3233\/JAD-215165_ref3","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.bcp.2013.12.024","article-title":"Alzheimer disease: Epidemiology, diagnostic criteria, risk factors and biomarkers","volume":"88","author":"Reitz","year":"2014","journal-title":"Biochem Pharmacol"},{"key":"10.3233\/JAD-215165_ref5","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/ene.13439","article-title":"Alzheimer\u2019s disease","volume":"25","author":"Lane","year":"2018","journal-title":"Eur J Neurol"},{"key":"10.3233\/JAD-215165_ref6","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1212\/01.WNL.0000129697.01779.0A","article-title":"The importance of neuritic plaques and tangles to the development and evolution of AD","volume":"62","author":"Tiraboschi","year":"2004","journal-title":"Neurology"},{"key":"10.3233\/JAD-215165_ref7","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","article-title":"Amyloid-beta and tau: The trigger and bullet in Alzheimer disease pathogenesis","volume":"71","author":"Bloom","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-215165_ref8","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ana.410100203","article-title":"Alzheimer\u2019s disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis","volume":"10","author":"Whitehouse","year":"1981","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-215165_ref9","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1126\/science.7058341","article-title":"Alzheimer\u2019s disease and senile dementia: Loss of neurons in basal forebrain","volume":"215","author":"Whitehouse","year":"1982","journal-title":"Science"},{"key":"10.3233\/JAD-215165_ref10","doi-asserted-by":"crossref","unstructured":"English BA , Webster AA (2012) Acetylcholinesterase and its inhibitors. In Primer on the Autonomic Nervous System, Robertson D, Biaggioni I, Burnstock G, Low P, Paton J, eds. Elsevier, Academic Press, pp. 631\u2013633.","DOI":"10.1016\/B978-0-12-386525-0.00132-3"},{"key":"10.3233\/JAD-215165_ref11","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1001\/jama.1994.03510370037029","article-title":"A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer\u2019s disease. The Tacrine Study Group","volume":"271","author":"Knapp","year":"1994","journal-title":"JAMA"},{"key":"10.3233\/JAD-215165_ref12","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1001\/jama.1994.03510370044030","article-title":"Hepatotoxic effects of tacrine administration in patients with Alzheimer\u2019s disease","volume":"271","author":"Watkins","year":"1994","journal-title":"JAMA"},{"key":"10.3233\/JAD-215165_ref13","doi-asserted-by":"crossref","first-page":"656","DOI":"10.7326\/M19-3887","article-title":"Benefits and harms of prescription drugs and supplements for treatment of clinical Alzheimer-type dementia","volume":"172","author":"Fink","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.3233\/JAD-215165_ref14","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/psc.2974","article-title":"Molecular design and synthesis of novel peptides from amphibians skin acting as inhibitors of cholinesterase enzymes","volume":"23","author":"Siano","year":"2017","journal-title":"J Pept Sci"},{"key":"10.3233\/JAD-215165_ref15","doi-asserted-by":"crossref","first-page":"104351","DOI":"10.1016\/j.bioorg.2020.104351","article-title":"Design, synthesis and biological evaluation of anticholinesterase peptides: Fragment-based vs. template-based peptide design","volume":"105","author":"Tahmasebi","year":"2020","journal-title":"Bioorg Chem"},{"key":"10.3233\/JAD-215165_ref16","first-page":"1899","article-title":"On the alkaloids of Galanthus woronowi. II. Isolation of a new alkaloid (in Russian)","volume":"22","author":"Proskurnina","year":"1952","journal-title":"Zh Obshch Khim"},{"key":"10.3233\/JAD-215165_ref17","unstructured":"Paskov DS (1959) Nivalin: Pharmacology and Clinical Application, Medicina i Fizkultura, Sofia, Bulgaria."},{"key":"10.3233\/JAD-215165_ref18","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0014-2999(00)00093-5","article-title":"Allosteric modulation of nicotinic acetylcholine receptors as a treatment strategy for Alzheimer\u2019s disease","volume":"393","author":"Maelicke","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.3233\/JAD-215165_ref19","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1124\/jpet.102.045773","article-title":"Galantamine is an allosterically potentiating ligand of neuronal nicotinic but not of muscarinic acetylcholine receptors","volume":"305","author":"Samochocki","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.3233\/JAD-215165_ref20","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/ana.410420205","article-title":"Nicotinic receptor stimulation protects neurons against beta-amyloid toxicity","volume":"42","author":"Kihara","year":"1997","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-215165_ref21","doi-asserted-by":"crossref","first-page":"13541","DOI":"10.1074\/jbc.M008035200","article-title":"alpha 7 nicotinic receptor transduces signals to phosphatidylinositol 3-kinase to block A beta-amyloid-induced neurotoxicity","volume":"276","author":"Kihara","year":"2001","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-215165_ref22","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1749-6632.1996.tb34445.x","article-title":"Nicotine-induced protection against glutamate cytotoxicity. Nicotinic cholinergic receptor-mediated inhibition of nitric oxide formation","volume":"777","author":"Shimohama","year":"1996","journal-title":"Ann N Y Acad Sci"},{"key":"10.3233\/JAD-215165_ref23","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jns.2009.01.024","article-title":"Galantamine inhibits \u03b2-amyloid aggregation and cytotoxicity","volume":"280","author":"Matharua","year":"2009","journal-title":"J Neurol Sci"},{"key":"10.3233\/JAD-215165_ref24","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.2147\/CIA.S184968","article-title":"Identification of the optimal cognitive drugs among Alzheimer\u2019s disease: A Bayesian meta-analytic review","volume":"13","author":"Liang","year":"2018","journal-title":"Clin Interv Aging"},{"key":"10.3233\/JAD-215165_ref25","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/gps.4405","article-title":"The comparative efficacy and safety of cholinesterase inhibitors in patients with mild-to-moderate Alzheimer\u2019s disease: A Bayesian network meta-analysis","volume":"31","author":"Kobayashi","year":"2016","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.3233\/JAD-215165_ref26","doi-asserted-by":"crossref","first-page":"777","DOI":"10.2165\/00002512-200320100-00006","article-title":"A long-term comparison of galantamine and donepezil in the treatment of Alzheimer\u2019s disease","volume":"20","author":"Wilcock","year":"2003","journal-title":"Drugs Aging"},{"key":"10.3233\/JAD-215165_ref27","first-page":"728","article-title":"Pharmacological evaluation of novel Alzheimer\u2019s disease therapeutics: Acetylcholinesterase inhibitors related to galanthamine","volume":"277","author":"Bores","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.3233\/JAD-215165_ref28","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/S0968-0896(98)00133-3","article-title":"Potent acetylcholinesterase inhibitors: Design, synthesis, and structure activity relationships of bis-interacting ligands in the galanthamine series","volume":"6","author":"Mary","year":"1998","journal-title":"Bioorg Med Chem"},{"key":"10.3233\/JAD-215165_ref29","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0960-894X(00)00059-7","article-title":"Potent acetylcholinesterase inhibitors: Design, synthesis and structure activity relationships of alkylene linked bis-galanthamine and galanthamine-galanthaminium salts","volume":"10","author":"Guillou","year":"2000","journal-title":"Bioorg Med Chem Lett"},{"key":"10.3233\/JAD-215165_ref30","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s00894-002-0086-9","article-title":"Galanthamine as bis-functional ligand for the acetylcholinesterase","volume":"8","author":"Luttmann","year":"2002","journal-title":"J Mol Model"},{"key":"10.3233\/JAD-215165_ref31","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.ejmech.2008.04.018","article-title":"Design, synthesis and evaluation of galanthamine derivatives as acetylcholinesterase inhibitors","volume":"44","author":"Jia","year":"2009","journal-title":"Eur J Med Chem"},{"key":"10.3233\/JAD-215165_ref32","doi-asserted-by":"crossref","first-page":"10248","DOI":"10.2174\/092986609789055412","article-title":"Synthesis and characterization of new galanthamine derivatives comprising peptide moiety","volume":"16","author":"Vezenkov","year":"2009","journal-title":"Protein Pept Lett"},{"key":"10.3233\/JAD-215165_ref33","doi-asserted-by":"crossref","first-page":"600","DOI":"10.2174\/156720512800618044","article-title":"Galantamine-based hybrid molecules with acetylcholinesterase, butyrylcholinesterase and \u03b3-secretase inhibition activities","volume":"9","author":"Vezenkov","year":"2012","journal-title":"Curr Alzheimer Res"},{"key":"10.3233\/JAD-215165_ref34","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3389\/fnmol.2017.00294","article-title":"Modifications and tra-cking of APP in the pathogenesis of Alzheimer\u2019s disease","volume":"10","author":"Wang","year":"2017","journal-title":"Front Mol Neurosci"},{"key":"10.3233\/JAD-215165_ref35","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2174\/1567205016666190228123923","article-title":"Synthesis of new galanthamine-peptide derivatives designed for prevention and treatment of Alzheimer\u2019s disease","volume":"16","author":"Vezenkov","year":"2019","journal-title":"Curr Alzheimer Res"},{"key":"10.3233\/JAD-215165_ref36","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1021\/jm0101803","article-title":"Structure-based design: Potent inhibitors of human brain memapsin 2 (beta-secretase)","volume":"44","author":"Ghosh","year":"2001","journal-title":"J Med Chem"},{"key":"10.3233\/JAD-215165_ref37","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2174\/1567205043331983","article-title":"Neurodegenerative disorders and cholesterol","volume":"1","author":"Michikawa","year":"2004","journal-title":"Curr Alzheimer Res"},{"key":"10.3233\/JAD-215165_ref38","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1006\/nbdi.2001.0422","article-title":"A cholesterol-lowering drug reduces beta-amyloid pathology in a transgenic mouse model of Alzheimer\u2019s disease","volume":"8","author":"Refolo","year":"2001","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JAD-215165_ref39","doi-asserted-by":"crossref","first-page":"735","DOI":"10.4065\/78.6.735","article-title":"Niacin as a component of combination therapy for dyslipidemia","volume":"78","author":"Miller","year":"2003","journal-title":"Mayo Clin Proc"},{"key":"10.3233\/JAD-215165_ref40","first-page":"195","article-title":"Nicotinic acid and its derivatives: A short survey","volume":"20","author":"Hotz","year":"1983","journal-title":"Adv Lipid Res"},{"key":"10.3233\/JAD-215165_ref41","doi-asserted-by":"crossref","unstructured":"Quack G , Puglisi L , Schatton W , Schwaier A (1987) Evaluation of hypolipidemic and other useful pharmacological properties of various nicotinic acid derivatives. In Drugs Affecting Lipid Metabolism, Paoletti R, Kritchevsky D, Holmes WL, eds. Proceedings in Life Sciences, Springer, Berlin, Heidelberg, pp. 376\u2013379.","DOI":"10.1007\/978-3-642-71702-4_70"},{"key":"10.3233\/JAD-215165_ref42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11883-016-0570-9","article-title":"Niacin alternatives for dyslipidemia: Fool\u2019s gold or gold mine? Part II: Novel niacin mimetics","volume":"18","author":"Goel","year":"2016","journal-title":"Curr Atheroscler Rep"},{"key":"10.3233\/JAD-215165_ref43","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1016\/j.bmc.2019.06.012","article-title":"Anti-atherosclerosis effect of H2S donors based on nicotinic acid and chlorfibrate structures","volume":"27","author":"Bai","year":"2019","journal-title":"Bioorganic Med Chem"},{"key":"10.3233\/JAD-215165_ref44","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s11030-020-10039-9","article-title":"New nicotinic acid-based 3,5-diphenylpyrazoles: Design, synthesis and antihyperlipidemic activity with potential NPC1L1 inhibitory activity","volume":"25","author":"Shoman","year":"2021","journal-title":"Mol Divers"},{"key":"10.3233\/JAD-215165_ref45","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF00971360","article-title":"Niacinamide transport through the blood-brain barrier","volume":"12","author":"Spector","year":"1987","journal-title":"Neurochem Res"},{"key":"10.3233\/JAD-215165_ref46","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-210577"},{"key":"10.3233\/JAD-215165_ref47","first-page":"576","article-title":"Antagonism by antimuscarinic and neuroleptic compounds at the five cloned human muscarinic cholinergic receptors expressed in Chinese hamster ovary cells","volume":"260","author":"Bolden","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"10.3233\/JAD-215165_ref48","first-page":"449","article-title":"Investigations of the amnesic properties of scopolamine and related compounds","volume":"127","author":"Domer","year":"1960","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"10.3233\/JAD-215165_ref49","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0028-3908(65)90025-0","article-title":"Amnesic properties of scopolamine and brain acetylcholine in the rat","volume":"4","author":"Pazzagli","year":"1965","journal-title":"Int J Neuropharmacol"},{"key":"10.3233\/JAD-215165_ref50","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1001\/archneur.1974.00490320001001","article-title":"Human memory and the cholinergic system: A relationship to aging?","volume":"30","author":"Drachman","year":"1974","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-215165_ref51","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0163-1047(86)80008-5","article-title":"The effects of physostigmine and scopolamine on recognition memory in monkeys","volume":"45","author":"Aigner","year":"1986","journal-title":"Behav Neural Biol"},{"key":"10.3233\/JAD-215165_ref52","first-page":"145","article-title":"The effects of scopolamine on working memory in healthy young volunteers","volume":"96","author":"Rusted","year":"1988","journal-title":"Psychopharmacology"},{"key":"10.3233\/JAD-215165_ref53","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/BF00442806","article-title":"Comparison of the effects of four cholinomimetic agents on cognition in primates following disruption by scopolamine or by lists of objects","volume":"99","author":"Rupniak","year":"1989","journal-title":"Psychopharmacology"},{"key":"10.3233\/JAD-215165_ref54","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.neubiorev.2010.04.001","article-title":"The validity of scopolamine as a pharmacological model for cognitive impairment: A review of animal behavioral studies","volume":"34","author":"Klinkenberg","year":"2010","journal-title":"Neurosci Biobehav Rev"},{"key":"10.3233\/JAD-215165_ref55","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1111\/bcp.13031","article-title":"Model-based exposure-response analysis to quantify age related differences in the response to scopolamine in healthy subjects","volume":"82","author":"Alvarez-Jimenez","year":"2016","journal-title":"Br J Clin Pharmacol"},{"key":"10.3233\/JAD-215165_ref56","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1007\/s12035-014-9051-8","article-title":"Bone marrow-derived endothelial progenitor cells protect against scopolamine-induced Alzheimer-like pathological aberrations","volume":"53","author":"Safar","year":"2016","journal-title":"Mol Neurobiol"},{"key":"10.3233\/JAD-215165_ref57","doi-asserted-by":"crossref","first-page":"593","DOI":"10.4103\/0253-7613.100383","article-title":"Supplementation of Convolvulus pluricaulis attenuates scopolamine-induced increased tau and amyloid precursor protein (AbetaPP) expression in rat brain","volume":"44","author":"Bihaqi","year":"2012","journal-title":"Indian J Pharmacol"},{"key":"10.3233\/JAD-215165_ref58","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.brainresbull.2016.10.002","article-title":"Scopolamine-induced greater alterations in neurochemical profile and increased oxidative stress demonstrated a better model of dementia: A comparative study","volume":"127","author":"Haider","year":"2016","journal-title":"Brain Res Bull"},{"key":"10.3233\/JAD-215165_ref59","doi-asserted-by":"crossref","first-page":"116695","DOI":"10.1016\/j.lfs.2019.116695","article-title":"The cellular and molecular processes associated with scopolamine-induced memory deficit: A model of Alzheimer\u2019s biomarkers","volume":"233","author":"Tang","year":"2019","journal-title":"Life Sci"},{"key":"10.3233\/JAD-215165_ref60","doi-asserted-by":"crossref","first-page":"10540","DOI":"10.1073\/pnas.88.23.10540","article-title":"Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease","volume":"88","author":"Smith","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-215165_ref61","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3233\/JAD-2008-15110","article-title":"Peripheral oxidative damage in mild cognitive impairment and mild Alzheimer\u2019s disease","volume":"15","author":"Baldeiras","year":"2008","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-215165_ref62","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1080\/10715760802255764","article-title":"Malondialdehyde, carbonyl proteins and albumin disulphide as useful oxidative markers in mild cognitive impairment and Alzheimer\u2019s disease","volume":"42","author":"Greilberger","year":"2008","journal-title":"Free Radic Res"},{"key":"10.3233\/JAD-215165_ref63","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.neulet.2009.11.033","article-title":"Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer\u2019s disease","volume":"469","author":"Padurariu","year":"2010","journal-title":"Neurosci Lett"},{"key":"10.3233\/JAD-215165_ref64","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1177\/039463201202500204","article-title":"Mitochondrial alterations, oxidative stress and neuroinflammation in Alzheimer\u2019s disease","volume":"25","author":"Verri","year":"2012","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.3233\/JAD-215165_ref65","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1007\/s12035-014-9053-6","article-title":"Mechanism of oxidative stress and synapse dysfunction in the pathogenesis of Alzheimer\u2019s disease: Understanding the therapeutics strategies","volume":"53","author":"Kamat","year":"2016","journal-title":"Mol Neurobiol"},{"key":"10.3233\/JAD-215165_ref66","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.pneurobio.2016.04.001","article-title":"Monoaminergic neuropathology in Alzheimer\u2019s disease","volume":"151","author":"\u0160imi\u0107","year":"2017","journal-title":"Prog Neurobiol"},{"key":"10.3233\/JAD-215165_ref67","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.phrs.2018.03.010","article-title":"VDAC1, mitochondrial dysfunction, and Alzheimer\u2019s disease","volume":"131","author":"Shoshan-Barmatz","year":"2018","journal-title":"Pharmacol Res"},{"key":"10.3233\/JAD-215165_ref68","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s10517-020-05032-z","article-title":"Effect of original peptide derivatives of galantamine on passive avoidance in mice","volume":"170","author":"Kostadinova","year":"2020","journal-title":"Bull Exp Biol Med"},{"key":"10.3233\/JAD-215165_ref69","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2466\/pr0.1967.21.1.221","article-title":"An improved one-trial passive avoidance learning situation","volume":"21","author":"Jarvik","year":"1967","journal-title":"Psychol Rep"},{"key":"10.3233\/JAD-215165_ref70","unstructured":"Wenk GL (2001) Assessment of spatial memory using the T maze. Curr Protoc Neurosci Chapter 8, Unit 8.5B."},{"key":"10.3233\/JAD-215165_ref71","doi-asserted-by":"crossref","first-page":"e2930","DOI":"10.21769\/BioProtoc.2930","article-title":"Evaluating working memory on a T-maze in male rats","volume":"8","author":"Hussein","year":"2018","journal-title":"Bio Protoc"},{"key":"10.3233\/JAD-215165_ref72","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1515\/REVNEURO.2006.17.1-2.111","article-title":"Rearing on hind legs, environmental novelty, and the hippocampal formation","volume":"17","author":"Lever","year":"2006","journal-title":"Rev Neurosci"},{"key":"10.3233\/JAD-215165_ref73","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem Pharmacol"},{"key":"10.3233\/JAD-215165_ref74","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1038\/nprot.2006.378","article-title":"Assay for quantitative determination of glutathione and glutathione disulfide levels using enzymatic recycling method","volume":"1","author":"Rahman","year":"2006","journal-title":"Nat Protoc"},{"key":"10.3233\/JAD-215165_ref75","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.freeradbiomed.2016.12.033","article-title":"Assay of superoxide dismutase activity in a plate assay using WST-1","volume":"103","author":"Peskin","year":"2017","journal-title":"Free Radic Biol Med"},{"key":"10.3233\/JAD-215165_ref76","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/0091-3057(78)90380-5","article-title":"Method for the rapid determination of norepinephrine, dopamine, and serotonin in the same brain region","volume":"8","author":"Jacobowitz","year":"1978","journal-title":"Pharmacol Biochem Behav"},{"key":"10.3233\/JAD-215165_ref77","doi-asserted-by":"crossref","first-page":"9852536","DOI":"10.1155\/2016\/9852536","article-title":"Sodium tanshinone IIA sulfonate attenuates scopolamine-induced cognitive dysfunctions via improving cholinergic system","volume":"2016","author":"Xu","year":"2016","journal-title":"Biomed Res Int"},{"key":"10.3233\/JAD-215165_ref78","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ijdevneu.2013.12.006","article-title":"Neuroprotective effect of anthocyanins on acetylcholinesterase activity and attenuation of scopolamine-induced amnesia in rats","volume":"33","author":"Gutierres","year":"2014","journal-title":"Int J Dev Neurosci"},{"key":"10.3233\/JAD-215165_ref79","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.peptides.2014.07.018","article-title":"Novel peptide VIP-TAT with higher affinity for PAC1 inhibited scopolamine induced amnesia","volume":"60","author":"Yu","year":"2014","journal-title":"Peptides"},{"key":"10.3233\/JAD-215165_ref80","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1007\/s12035-014-8899-y","article-title":"Neuroprotective role of novel triazine derivatives by activating Wnt\/\u03b2 catenin signaling pathway in rodent models of Alzheimer\u2019s disease","volume":"52","author":"Sinha","year":"2015","journal-title":"Mol Neurobiol"},{"key":"10.3233\/JAD-215165_ref81","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1186\/s12906-017-1880-3","article-title":"The protective effect of fermented Curcuma longa L. on memory dysfunction in oxidative stress-induced C6 gliomal cells, proinflammatory-activated BV2 microglial cells, and scopolamine-induced amnesia model in mice","volume":"17","author":"Eun","year":"2017","journal-title":"BMC Complement Altern Med"},{"key":"10.3233\/JAD-215165_ref82","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.neulet.2016.12.012","article-title":"\u03b1-Isocubebenol alleviates scopolamine-induced cognitive impairment by repressing acetylcholinesterase activity","volume":"638","author":"Song","year":"2017","journal-title":"Neurosci Lett"},{"key":"10.3233\/JAD-215165_ref83","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s12640-017-9701-5","article-title":"Anti-amnestic effect of curcumin in combination with donepezil, an anticholinesterase drug: Involvement of cholinergic system","volume":"31","author":"Akinyemi","year":"2017","journal-title":"Neurotox Res"},{"key":"10.3233\/JAD-215165_ref84","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1006\/bbrc.1997.6357","article-title":"A monoclonal antibody against acetylcholinesterase inhibits the formation of amyloid fibrils induced by the enzyme","volume":"232","author":"Reyes","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"10.3233\/JAD-215165_ref85","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1523\/JNEUROSCI.18-09-03213.1998","article-title":"Stable complexes involving acetylcholinesterase and amyloid-beta peptide change the biochemical properties of the enzyme and increase the neurotoxicity of Alzheimer\u2019s fibrils","volume":"18","author":"Alvarez","year":"1998","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-215165_ref86","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1034\/j.1600-0404.2000.00308.x","article-title":"Acetylcholinesterase-amyloid-beta-peptide interaction and Wnt signaling involvement in Abeta neurotoxicity.","volume":"176","author":"Inestrosa","year":"2000","journal-title":"Acta Neurol Scand Suppl"},{"key":"10.3233\/JAD-215165_ref87","doi-asserted-by":"crossref","unstructured":"Pepeu G , Giovannini MG (2006) The role of the cholinergic system in cognitive processes. In The Brain Cholinergic System in Health and Disease, Giacobini E, Pepeu G, eds. Informa UK, pp. 221\u2013233.","DOI":"10.1201\/b14486-18"},{"key":"10.3233\/JAD-215165_ref88","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.cbi.2009.11.018","article-title":"Cholinesterase inhibitors and memory","volume":"187","author":"Pepeu","year":"2010","journal-title":"Chem Biol Interact"},{"key":"10.3233\/JAD-215165_ref89","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1248\/bpb.17.490","article-title":"Role of cholinergic neurotransmission in the amygdala on performances of passive avoidance learning in mice","volume":"17","author":"Nomura","year":"1994","journal-title":"Biol Pharm Bull"},{"key":"10.3233\/JAD-215165_ref90","doi-asserted-by":"crossref","first-page":"9824","DOI":"10.1038\/s41598-017-10437-4","article-title":"Ethyl acetate extract components of Bushen-Yizhi formula provides neuroprotection against scopolamine-induced cognitive impairment","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci Rep"},{"key":"10.3233\/JAD-215165_ref91","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0165-0173(93)90006-L","article-title":"The neuropharmacological and neurochemical basis of place learning in the Morris water maze","volume":"18","author":"McNamara","year":"1993","journal-title":"Brain Res Brain Res Rev"},{"key":"10.3233\/JAD-215165_ref92","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ejphar.2006.03.046","article-title":"Effect of scopolamine on the hippocampal theta rhythm during an eight-arm radial maze task in rats","volume":"539","author":"Masuoka","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.3233\/JAD-215165_ref93","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.nlm.2014.12.014","article-title":"The integrated role of ACh, ERK and mTOR in the mechanisms of hippocampal inhibitory avoidance memory","volume":"119","author":"Giovannini","year":"2015","journal-title":"Neurobiol Learn Mem"},{"key":"10.3233\/JAD-215165_ref94","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0028-3908(67)90008-1","article-title":"Impairment of one-trial passive avoidance learning in mice by scopolamine, scopolamine methylbromide, and physostigmine","volume":"6","author":"Bohdaneck\u00fd","year":"1967","journal-title":"Int J Neuropharmacol"},{"key":"10.3233\/JAD-215165_ref95","first-page":"279","article-title":"Effect of cholinergic drugs on passive avoidance in the mouse","volume":"158","author":"Dilts","year":"1967","journal-title":"J Pharmacol Exp Ther"},{"key":"10.3233\/JAD-215165_ref96","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/BF00401400","article-title":"Effects of scopolamine on acquisition of passive avoidance","volume":"13","author":"Calhoun","year":"1968","journal-title":"Psychopharmacologia"},{"key":"10.3233\/JAD-215165_ref97","first-page":"226","article-title":"Learning impairment after three classes of agents which modify cholinergic function","volume":"193","author":"Goldberg","year":"1971","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"10.3233\/JAD-215165_ref98","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0163-1047(88)90938-7","article-title":"Scopolamine amnesia of passive avoidance: A deficit of information acquisition","volume":"50","author":"Rush","year":"1988","journal-title":"Behav Neural Biol"},{"key":"10.3233\/JAD-215165_ref99","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0014-2999(96)00907-7","article-title":"D-cycloserine, a glycine site agonist, reverses working memory failure by hippocampal muscarinic receptor blockade in rats","volume":"318","author":"Ohno","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.3233\/JAD-215165_ref100","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0306-4522(97)00091-2","article-title":"Selective muscarinic antagonists differentially affect in vivo acetylcholine release and memory performances of young and aged rats","volume":"79","author":"Vannucchi","year":"1997","journal-title":"Neuroscience"},{"key":"10.3233\/JAD-215165_ref101","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/31371","article-title":"Mechanisms for memory types differ","volume":"393","author":"Izquierdo","year":"1998","journal-title":"Nature"},{"key":"10.3233\/JAD-215165_ref102","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.nlm.2013.09.013","article-title":"Hippocampal long term memory: Effect of the cholinergic system on local protein synthesis","volume":"106","author":"Lana","year":"2013","journal-title":"Neurobiol Learn Mem"},{"key":"10.3233\/JAD-215165_ref103","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-4328(99)00036-4","article-title":"Separate mechanisms for short- and long-term memory","volume":"103","author":"Izquierdo","year":"1999","journal-title":"Behav Brain Res"},{"key":"10.3233\/JAD-215165_ref104","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1023\/A:1020715800956","article-title":"Molecular pharmacological dissection of short- and long-term memory","volume":"22","author":"Izquierdo","year":"2002","journal-title":"Cell Mol Neurobiol"},{"key":"10.3233\/JAD-215165_ref105","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1023\/A:1007502918282","article-title":"Differential role of hippocampal cAMP-dependent protein kinase in short- and long-term memory","volume":"25","author":"Vianna","year":"2000","journal-title":"Neurochem Res"},{"key":"10.3233\/JAD-215165_ref106","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/BF00427569","article-title":"Memory and the septo-hippocampal cholinergic system in the rat","volume":"81","author":"Brito","year":"1983","journal-title":"Psychopharmacology (Berl)"},{"key":"10.3233\/JAD-215165_ref107","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0166-4328(90)90058-M","article-title":"Reinforced alternation performance is impaired by muscarinic but not by nicotinic receptor blockade in rats","volume":"36","author":"Clarke","year":"1990","journal-title":"Behav Brain Res"},{"key":"10.3233\/JAD-215165_ref108","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0031-9384(96)00176-X","article-title":"Of mice and mazes: Similarities between mice and rats on dry land but not water mazes","volume":"60","author":"Whishaw","year":"1996","journal-title":"Physiol Behav"},{"key":"10.3233\/JAD-215165_ref109","first-page":"6372059","article-title":"Scopolamine-induced memory impairment in mice: Neuroprotective effects of Carissa edulis (Forssk.) Valh (Apocynaceae) aqueous extract","volume":"2020","author":"Yadang","year":"2020","journal-title":"Int J Alzheimers Dis"},{"key":"10.3233\/JAD-215165_ref110","doi-asserted-by":"crossref","first-page":"e56870","DOI":"10.1371\/journal.pone.0056870","article-title":"Pharmacological characterization of memoquin, a multi-target compound for the treatment of Alzheimer\u2019s disease","volume":"8","author":"Capurro","year":"2013","journal-title":"PLoS One"},{"key":"10.3233\/JAD-215165_ref111","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1093\/brain\/awr189","article-title":"The clinical diagnosis of early-onset dementias: Diagnostic accuracy and clinicopathological relationships","volume":"134","author":"Snowden","year":"2011","journal-title":"Brain"},{"key":"10.3233\/JAD-215165_ref112","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0006-8993(97)00928-1","article-title":"Locomotion and stereotypy induced by scopolamine: Contributions of muscarinic receptors near the pedunculopontine tegmental nucleus","volume":"775","author":"Mathur","year":"1997","journal-title":"Brain Res"},{"key":"10.3233\/JAD-215165_ref113","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0091-3057(03)00196-5","article-title":"Role of cholinergic receptors in locomotion induced by scopolamine and oxotremorine-M","volume":"76","author":"Chintoh","year":"2003","journal-title":"Pharmacol Biochem Behav"},{"key":"10.3233\/JAD-215165_ref114","first-page":"974013","article-title":"Neuroprotective effects of meloxicam and selegiline in scopolamine-induced cognitive impairment and oxidative stress","volume":"2012","author":"Goverdhan","year":"2012","journal-title":"Int J Alzheimers Dis"},{"key":"10.3233\/JAD-215165_ref115","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.pbb.2006.07.007","article-title":"Pharmacological and genetic influences on hole-board behaviors in mice","volume":"85","author":"Kliethermes","year":"2006","journal-title":"Pharmacol Biochem Behav"},{"key":"10.3233\/JAD-215165_ref116","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3758\/BF03327209","article-title":"Neglected aspects of exploratory and investigatory behavior","volume":"18","author":"Renner","year":"1990","journal-title":"Psychobiology"},{"key":"10.3233\/JAD-215165_ref117","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/BF00411172","article-title":"The exploratory behaviour in normal and aggressive mice","volume":"15","author":"Valzelli","year":"1969","journal-title":"Psychopharmacologia (Berl)"},{"key":"10.3233\/JAD-215165_ref118","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.beproc.2013.12.002","article-title":"Behavioral effects of different enriched environments in mice treated with the cholinergic agonist PNU-282987","volume":"103","author":"Mesa-Gresa","year":"2014","journal-title":"Behav Processes"},{"key":"10.3233\/JAD-215165_ref119","doi-asserted-by":"crossref","first-page":"38933","DOI":"10.1074\/jbc.M110.132860","article-title":"Inhibitors of catalase amyloid interactions protect cells from \u03b2-amyloid induced oxidative stress and toxicity","volume":"285","author":"Habib","year":"2010","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-215165_ref120","doi-asserted-by":"crossref","first-page":"823","DOI":"10.3233\/JAD-2012-121528","article-title":"Oxidative stress in Alzheimer\u2019s disease and mild cognitive impairment with high sensitivity and specificity","volume":"33","author":"L\u00f3pez","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-215165_ref121","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1196\/annals.1427.010","article-title":"Evidence of oxidative stress in Alz-heimer\u2019s disease brain and antioxidant therapy: Lights and shadows","volume":"1147","author":"Pratic\u00f2","year":"2008","journal-title":"Ann NY Acad Sci"},{"key":"10.3233\/JAD-215165_ref122","doi-asserted-by":"crossref","first-page":"950","DOI":"10.3109\/10715762.2011.571682","article-title":"Prevention of scopolamine-induced memory deficits by schisandrin B, an antioxidant lignan from Schisandra chinensis in mice","volume":"45","author":"Giridharan","year":"2011","journal-title":"Free Radic Res"},{"key":"10.3233\/JAD-215165_ref123","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ejphar.2008.04.015","article-title":"Cognitive-enhancing and antioxidant activities of iridoid glycosides from Scrophularia buergeriana in scopolaminetreated mice","volume":"588","author":"Jeong","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.3233\/JAD-215165_ref124","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3892\/ijmm.2014.1801","article-title":"Bushen-Yizhi formula ameliorates cognition deficits and attenuates oxidative stress-related neuronal apoptosis in scopolamine-induced senescence in mice","volume":"34","author":"Hou","year":"2014","journal-title":"Int J Mol Med"},{"key":"10.3233\/JAD-215165_ref125","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S0165-0173(02)00268-0","article-title":"Neurotransmitter systems involved in learning and memory in the rat: A meta-analysis based on studies of four behavioral tasks.","volume":"41","author":"Myhrer","year":"2003","journal-title":"Brain Res Rev"},{"key":"10.3233\/JAD-215165_ref126","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1471-4159.1984.tb00913.x","article-title":"Changes of biogenic amines and their metabolites in postmortem brains from patients with Alzheimer-type dementia","volume":"43","author":"Arai","year":"1984","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-215165_ref127","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/BF00711237","article-title":"Monoamine neurotransmitters and their metabolites in brain regions in Alzheimer\u2019s disease: A postmortem study","volume":"12","author":"Nazarali","year":"1992","journal-title":"Cell Mol Neurobiol"},{"key":"10.3233\/JAD-215165_ref128","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0006-8993(87)91408-9","article-title":"Monoaminergic innervation of the frontal and temporal lobes in Alzheimer\u2019s disease.","volume":"401","author":"Palmer","year":"1987","journal-title":"Brain Res"},{"key":"10.3233\/JAD-215165_ref129","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.neubiorev.2013.05.008","article-title":"Ascending monoaminergic systems alterations in Alzheimer\u2019s disease. Translating basic science into clinical care","volume":"37","author":"Trillo","year":"2013","journal-title":"Neurosci Biobehav Rev"},{"key":"10.3233\/JAD-215165_ref130","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1515\/REVNEURO.1998.9.4.275","article-title":"Physiological, pathophysiological and therapeutic roles of 5-HT systems in learning and memory","volume":"9","author":"Meneses","year":"1998","journal-title":"Rev Neurosci"},{"key":"10.3233\/JAD-215165_ref131","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/0091-3057(87)90184-5","article-title":"The effects of 8-hydroxy-2-(di-n-propylamino)tetralin and other serotonergic agonists on performance in a radial maze: A possible role for 5-HT1A receptors in memory","volume":"27","author":"Winter","year":"1987","journal-title":"Pharmacol Biochem Behav"},{"key":"10.3233\/JAD-215165_ref132","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/BF00402088","article-title":"Behavioral effects of serotonin depletion and of p-chlorophenylalanine (a serotonin depletor) in rats","volume":"17","author":"Brody","year":"1978","journal-title":"Psychopharmacology"},{"key":"10.3233\/JAD-215165_ref133","first-page":"725","article-title":"Facilitation of complex maze learning in rats following selective deafferentation of the dorsal hippocampus","volume":"14","author":"Altman","year":"1988","journal-title":"Soc Neurosci Abstr"},{"key":"10.3233\/JAD-215165_ref134","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s002130100840","article-title":"5-HT6 receptor antagonists enhance retention of a water maze task in the rat","volume":"158","author":"Rogers","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"10.3233\/JAD-215165_ref135","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2174\/1568007043482561","article-title":"5-HT6 receptors","volume":"3","author":"Woolley","year":"2004","journal-title":"Curr Drug Targets CNS Neurol Disord"},{"key":"10.3233\/JAD-215165_ref136","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1038\/sj.npp.1300777","article-title":"The selective 5-HT6 receptor antagonist Ro4368554 restores memory performance in cholinergic and serotonergic models of memory deficiency in the rat","volume":"30","author":"Lieben","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.3233\/JAD-215165_ref137","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF02245055","article-title":"5-HT1A receptor agonists improve the performance of normal and scopolamine-impaired rats in an operant delayed matching to position task","volume":"116","author":"Cole","year":"1994","journal-title":"Psychopharmacology"},{"key":"10.3233\/JAD-215165_ref138","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000117673","article-title":"Effect of p-chloro-phenylalanine on avoidance learning of two differentially housed mouse strains","volume":"5","author":"Valzelli","year":"1979","journal-title":"Neuropsychobiology"},{"key":"10.3233\/JAD-215165_ref139","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0024-3205(83)90080-2","article-title":"Effect of specific serotonergic lesions on cholinergic neurons in the hippocampus, cortex and striatum","volume":"32","author":"Robinson","year":"1983","journal-title":"Life Sci"},{"key":"10.3233\/JAD-215165_ref140","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0306-4522(94)90599-1","article-title":"Serotonergic and cholinergic inhibition of mesopontine cholinergic neurons controlling REM sleep: An in vitro electrophysiological study","volume":"59","author":"Leonard","year":"1994","journal-title":"Neuroscience"},{"key":"10.3233\/JAD-215165_ref141","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0006-8993(78)90951-4","article-title":"Evidence for an interaction between serotonergic and cholinergic neurons in the corpus striatum and hippocampus of the rat brain","volume":"151","author":"Samanin","year":"1978","journal-title":"Brain Res"},{"key":"10.3233\/JAD-215165_ref142","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0306-4522(95)00241-A","article-title":"Serotonergic modulation of cholinergic function in the central nervous system: Cognitive implications","volume":"69","author":"Cassel","year":"1995","journal-title":"Neuroscience"},{"key":"10.3233\/JAD-215165_ref143","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0166-4328(94)00157-B","article-title":"The role of serotonergiccholinergic interactions in the mediation of cognitive behavior","volume":"67","author":"Steckler","year":"1995","journal-title":"Behav Brain Res"},{"key":"10.3233\/JAD-215165_ref144","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF02244194","article-title":"Serotonin, memory, and the aging brain","volume":"103","author":"McEntee","year":"1991","journal-title":"Psychopharmacology (Berl)"},{"key":"10.3233\/JAD-215165_ref145","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3758\/BF03327157","article-title":"Fluoxetine effects on retention of inhibitory avoidance: Enhancement by systemic but not intra-amygdala injections","volume":"20","author":"Introni-Collison","year":"1992","journal-title":"Psychobiology"},{"key":"10.3233\/JAD-215165_ref146","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00004850-199400910-00006","article-title":"Verbal learning by major depressive disorder patients during treatment with fluoxetine or amitriptyline","volume":"9","author":"Richardson","year":"1994","journal-title":"Int Clin Psychopharmacol"},{"key":"10.3233\/JAD-215165_ref147","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s002130050845","article-title":"Tryptophan depletion in normal volunteers produces selective impairment in memory consolidation","volume":"141","author":"Riedel","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"key":"10.3233\/JAD-215165_ref148","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1017\/S0033291702006906","article-title":"Effects of acute tryptophan depletion on cognitive function in Alzheimer\u2019s disease and in the healthy elderly","volume":"33","author":"Porter","year":"2003","journal-title":"Psychol Med"},{"key":"10.3233\/JAD-215165_ref149","first-page":"4942","article-title":"Evidence for a possible functional interaction between serotonergic and cholinergic mechanisms in memory retrieval","volume":"148","author":"Altman","year":"1987","journal-title":"Behav Neural Bio"},{"key":"10.3233\/JAD-215165_ref150","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/0006-8993(95)00730-E","article-title":"Extracellular concentrations of serotonin in the dorsal hippocampus after acute and chronic treatment with citalopram","volume":"696","author":"Invernizzi","year":"1995","journal-title":"Brain Res"},{"key":"10.3233\/JAD-215165_ref151","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1046\/j.1471-4159.1994.62062254.x","article-title":"Serotonergic facilitation of acetylcholine release in vivo from rat dorsal hippocampus via serotonin 5-HT3 receptors","volume":"62","author":"Consolo","year":"1994","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-215165_ref152","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1007\/PL00005110","article-title":"Facilitation of acetylcholine release in rat frontal cortex by indeloxazine hydrochloride: Involvement of endogenous serotonin and 5-HT4 receptors","volume":"356","author":"Yamaguchi","year":"1997","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.3233\/JAD-215165_ref153","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.pbb.2006.01.006","article-title":"Low dose citalopram reverses memory impairment and electroconvulsive shock-induced immobilization","volume":"83","author":"Egashira","year":"2006","journal-title":"Pharmacol Biochem Behav"},{"key":"10.3233\/JAD-215165_ref154","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.neuint.2010.02.001","article-title":"Induced LC degeneration in APP\/PS1 transgenic mice accelerates early cerebral amyloidosis and cognitive deficits","volume":"57","author":"Jardanhazi-Kurutz","year":"2010","journal-title":"Neurochem Int"},{"key":"10.3233\/JAD-215165_ref155","doi-asserted-by":"crossref","first-page":"6058","DOI":"10.1073\/pnas.0909586107","article-title":"Locus ceruleus controls Alzheimer\u2019s disease pathology by modulating microglial functions through norepinephrine","volume":"107","author":"Heneka","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-215165_ref156","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40478-017-0411-2","article-title":"Locus coeruleus cellular and molecular pathology during the progression of Alzheimer\u2019s disease","volume":"5","author":"Kelly","year":"2017","journal-title":"Acta Neuropathol Commun"},{"key":"10.3233\/JAD-215165_ref157","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1136\/jnnp.47.2.201","article-title":"A comparison of changes in the nucleus basalis and locus caeruleus in Alzheimer\u2019s disease","volume":"47","author":"Mann","year":"1984","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JAD-215165_ref158","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/archneur.60.3.337","article-title":"Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases","volume":"60","author":"Zarow","year":"2003","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-215165_ref159","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1017\/S0033291700003032","article-title":"Cortical noradrenaline, attention and arousal","volume":"14","author":"Robbins","year":"1984","journal-title":"Psychol Med"},{"key":"10.3233\/JAD-215165_ref160","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0165-0173(03)00143-7","article-title":"The locus coeruleus-noradrenergic system: Modulation of behavioral state and state-dependent cognitive processes","volume":"42","author":"Berridge","year":"2003","journal-title":"Brain Res Brain Res Rev"},{"key":"10.3233\/JAD-215165_ref161","doi-asserted-by":"crossref","first-page":"7416","DOI":"10.1523\/JNEUROSCI.1001-06.2006","article-title":"The locus ceruleus is involved in the successful retrieval of emotional memories in humans","volume":"26","author":"Sterpenich","year":"2006","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-215165_ref162","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nrn2573","article-title":"The locus coeruleus and noradrenergic modulation of cognition","volume":"10","author":"Sara","year":"2009","journal-title":"Nat Rev Neurosci"},{"key":"10.3233\/JAD-215165_ref163","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.tics.2016.01.001","article-title":"The locus coeruleus: Essential for maintaining cognitive function and the aging brain","volume":"20","author":"Mather","year":"2016","journal-title":"Trends Cogn Sci"},{"key":"10.3233\/JAD-215165_ref164","doi-asserted-by":"crossref","first-page":"992","DOI":"10.2174\/1567205011666141107130505","article-title":"Locus (coeruleus) minoris resistentiae in pathogenesis of Alzheimer\u2019s disease","volume":"11","author":"Mravec","year":"2014","journal-title":"Curr Alzheimer Res"},{"key":"10.3233\/JAD-215165_ref165","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.biopsych.2012.06.013","article-title":"Selective loss of noradrenaline exacerbates early cognitive dysfunction and synaptic deficits in APP\/PS1 mice","volume":"73","author":"Hammerschmidt","year":"2013","journal-title":"Biol Psychiatry"},{"key":"10.3233\/JAD-215165_ref166","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.neurobiolaging.2007.11.010","article-title":"Levodopa ameliorates learning and memory deficits in a murine model of Alzheimer\u2019s disease","volume":"30","author":"Ambree","year":"2009","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-215165_ref167","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1101\/lm.026070.112","article-title":"Restoration of dopamine release deficits during object recognition memory acquisition attenuates cognitive impairment in a triple transgenic mice model of Alzheimer\u2019s disease","volume":"19","author":"Guzman-Ramos","journal-title":"Learn Mem"},{"key":"10.3233\/JAD-215165_ref168","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S0163-1047(85)90640-5","article-title":"Alternation behavior, spatial discrimination, and reversal disturbances following 6-hydroxydopamine lesions in the nucleus accumbens of the rat","volume":"44","author":"Taghzouti","year":"1985","journal-title":"Behav Neural Biol"},{"key":"10.3233\/JAD-215165_ref169","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0166-4328(86)90042-2","article-title":"Deficits in spatial-memory tasks following lesions of septal dopaminergic terminals in the rat","volume":"19","author":"Simon","year":"1986","journal-title":"Behav Brain Res"},{"key":"10.3233\/JAD-215165_ref170","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/s12031-018-1171-6","article-title":"Preventive effect of two new neurotensin analogues on Parkinson\u2019s disease rat model","volume":"66","author":"Lazarova","year":"2018","journal-title":"J Mol Neurosci"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-215165","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:07:23Z","timestamp":1777370843000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-215165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,9]]},"references-count":168,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3233\/jad-215165","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,9]]}}}